NCT05185388Active, not recruiting
Socioeconomic Inequalities in the Diagnosis and Treatment of Colon and Ovarian Cancer in England Between 2016-2017
Socioeconomic Inequalities in the Diagnosis and Treatment of Colon and Ovarian Cancer in England Between 2016-2017: A Data Linkage Study Linking National Cancer Registration and Analysis Service, Hospital Episode Statistics and NHS Digital Datasets
Source: ClinicalTrials.gov · Last updated 11 May 2026
Brief summary (registry, in English)
This study is a population-based, patient-level analysis of colon and ovarian cancer diagnoses in England over a 2-year period using a dataset created by linking NCRAS and NHS digital datasets. Our analyses will look into inequalities in the diagnostic and treatment pathway, and inequalities in treatment received, for those diagnosed with colon and ovarian cancer between 2016-2017.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 45831 (actual)
- First submitted
- 22 Dec 2021
- Start date
- 25 Oct 2021
- Primary completion date
- Nov 2027
- Lead sponsor
- University of Hull
- Diseases
- Ovarian cancer
- NCT number
- NCT05185388
What you commit to
- Study type: Observational
- Participants enrolled: 45831
- From 25 Oct 2021 to the primary completion date, Nov 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with cancers of the appendix (C18.1) will be excluded.
- Male patients with ovarian cancer.
- Patients diagnosed with any prior invasive primary malignancies (ICD10 C00-97x), where the date of diagnosis of such prior invasive malignancies precedes the diagnosis date of the first qualifying tumour. Patients with a synchronous diagnosis on the same day as their qualifying tumour will be included within the sample population.
Other
- Borderline ovarian tumours (ICD-10 site code of C56x, C57x or C48x where the morphology code is: 8442, 8444, 8451, 8463, 8473, 8472 or 8462) and (ICD-10 site code D39.1 where the morphology code is 8144, 8260, 8313, 8380, 8381, 8440, 8441, 8460, 8470, 8480, 8481, 9000, 9013, 9014 or 9015).
- Sarcomas are excluded (where the morphology code is: 8693, 8800-8806, 8963, 8990-8991, 9040-9044, 8810, 8811-8921, 9120-9373, 9490, 9500, 9530-9582).
- Incomplete registrations excluded.
Who the study is looking for
- All patients resident in England and aged 18-99 diagnosed with colon cancer (ICD10 C18) or ovarian cancer (ICD10 C48, C56, C57 and D39,1) where the date of diagnosis is between 01/01/2016 and 31/12/2017.
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hull York Medical School Coordinator of this site? Confirm its status | Hull | United Kingdom | Unknown status |
Related publications
- Are there inequalities in colon cancer diagnosis and treatment in England? A population-based study.Cancer Epidemiol · 2026 · PMID 42731437
This page is information, not medical advice. Discuss any trial with your doctor.